<DOC>
	<DOCNO>NCT02787590</DOCNO>
	<brief_summary>Participants randomly allocate one two treatment group . In one group , participant give capsule simvastatin take orally ( mouth ) 24 month . In group , participant give placebo ( dummy ) capsule take orally 24 month . At start study , receive medication , participant complete number questionnaire motor ( movement ) test ( walk test finger tap test ) . Participants group also attend 6 clinic visit 1 , 6 , 12 , 18 24 26 month , ask health medication taking , well repeat questionnaire motor test . For 4 clinic visit , participant ask attend 'OFF medication ' state ( omit usual PD medication ) researcher get true picture disease without mask normal medication .</brief_summary>
	<brief_title>Simvastatin Neuroprotective Treatment Moderate Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Diagnosis idiopathic PD Modified Hoehn Yahr stage â‰¤ 3.0 ON medication state Age 4090 year On dopaminergic treatment wearingoff phenomenon Able comply study protocol willing attend necessary study visit Diagnosis suspicion cause parkinsonism Known abnormality CT MRI brain imaging consider cause symptom sign neurological dysfunction , consider likely compromise compliance study protocol Concurrent dementia define MoCA score &lt; 21 Concurrent severe depression define MADRS score &gt; 31 Prior intracerebral surgical intervention PD include deep brain stimulation , lesional surgery , growth factor administration , gene therapy cell transplantation Already actively participate research study might conflict trial Prior current use statin lipid lower therapy Intolerance statin Untreated hypothyroidism End stage renal disease ( creatinine clearance &lt; 30 mL/min ) history severe cardiac disease ( angina , myocardial infarction cardiac surgery precede two year ) eGFR &lt; 30 mL/min History alcoholism liver impairment Creatine kinase ( CK ) &gt; 1.1 x upper limit normal ( ULN ) Aspartate transaminase ( AST ) alanine transaminase ( ALT ) &gt; 1.1 x ULN Females pregnant breast feed childbearing potential unwilling use appropriate contraception method whilst trial treatment Currently take medication contraindicate simvastatin use ( Appendix 2 ) Any requirement statin use Regular participation endurance highimpact sport Unable abstain consumption grapefruitbased product</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Neurology</keyword>
</DOC>